Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2003

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2003. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Theresa Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​oc/​advisory/​default.htm. The FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2003. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area):

Start Printed Page 77794
Committee NameDates of MeetingsAdvisory Committee 5-Digit Information Line Code
OFFICE OF THE COMMISSIONER
Science Board to the Food and Drug AdministrationApril 9, November 612603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeApril 8, November 1812388
Biological Response Modifiers Advisory CommitteeFebruary 27-28, June 9-10, October 9-1012389
Blood Products Advisory CommitteeMarch 13-14, June 19-20, September 18-19, December 11-1219516
Transmissible Spongiform Encephalopathies Advisory CommitteeFebruary 20-21, July 17-18, October 30-3112932
Vaccines and Related Biological Products Advisory CommitteeFebruary 20-21, May 8-9, September 22-23, November 19-2012391
CENTER FOR DRUG EVALUATION AND RESEARCH
Advisory Committee for Pharmaceutical ScienceFebruary 12-13, March 12-13, September 17, October 21-2312539
Advisory Committee for Reproductive Health DrugsMarch 24-25, August 18-19, November 13-1412537
Anesthetic and Life Support Drugs Advisory CommitteeJune 26-27, December 11-1212529
Anti-Infective Drugs Advisory CommitteeJanuary 8-9, March 4-5, June 10-11, October 15-1612530
Antiviral Drugs Advisory CommitteeApril 29-30, September 1912531
Arthritis Advisory CommitteeJanuary 30-31, September 512532
Cardiovascular and Renal Drugs Advisory CommitteeJanuary 6-7, May 29-30, September 15-16, December 11-1212533
Dermatologic and Ophthalmic Drugs Advisory CommitteeMarch 6-7, April 15-16, July 17-18, September 10-1112534
Drug Safety and Risk Management Advisory CommitteeApril 24-25, September 18-1912535
Endocrinologic and Metabolic Drugs Advisory CommitteeJanuary 13-15, June 12-13, September 11-1212536
Gastrointestinal Drugs Advisory CommitteeJuly 1712538
Nonprescription Drugs Advisory CommitteeMarch 6-7, June 13-14, September 16-1712541
Start Printed Page 77795
Oncologic Drugs Advisory CommitteeMarch 3-4, March 12-13, June 10-1112542
Peripheral and Central Nervous System Drugs Advisory CommitteeJuly 1812543
Psychopharmacologic Drugs Advisory CommitteeFebruary 27-28, September 4-512544
Pulmonary-Allergy Drugs Advisory CommitteeMay 15-16, November 6-712545
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeFebruary 24-26, August 18-2010564
Biotechnology Sub-CommitteeMarch 24-25, October 15-1610564
Dietary Supplements Sub-CommitteeMarch 27-28, September 22-2310564
Contaminants and Natural Toxicants Sub-CommitteeMarch 6-7, September 4-510564
Nutrition Sub-CommitteeApril 28-29, November 3-410564
Food Additives Sub-CommitteeJune 19-2010564
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeNo meetings planned12398
Medical Devices Advisory Committee:
Anesthesiology and Respiratory Therapy Devices PanelMarch 27-28, May 7-8, September 4-5, November 10-1112624
Circulatory System Devices PanelFebruary 21-22, April 24-25, June 26-27, August 28-29, October 23-24, December 11-1212625
Clinical Chemistry and Clinical Toxicology Devices PanelFebruary 10-11, May 19, September 8-9, December 11-1212514
Dental Products PanelFebruary 13-14, May 22-23, August 7-8, October 9-1012518
Ear, Nose, and Throat Devices PanelApril 8-9, June 2-3, August 4-5, October 9-10, December 4-512522
Gastroenterology and Urology Devices PanelJanuary 17, April 4, July 25, October 1712523
General and Plastic Surgery Devices PanelFebruary 27-28, April 10-11, July 23-24, October 23-2412519
General Hospital and Personal Use Devices PanelFebruary 27-28, May 15-16, August 18-19, November 20-2112520
Start Printed Page 77796
Hematology and Pathology Devices PanelMarch 14, June 20, October 312515
Immunology Devices PanelMarch 17-18, June 9-10, September 15-1612516
Medical Devices Dispute Resolution PanelNo meetings planned10232
Microbiology Devices PanelMarch 27-28, May 5-6, August 7-8, October 16-1712517
Molecular and Clinical Genetics PanelApril 24-25, July 17-18, November 13-1410231
Neurological Devices PanelMarch 6-7, June 23-24, September 18-19, December 8-912513
Obstetrics and Gynecology Devices PanelMarch 3-4, June 9-10, September 8-9, November 3-412524
Ophthalmic Devices PanelMarch 13-14, May 22-23, July 10-11, September 11-12, November 6-712396
Orthopaedic and Rehabilitation Devices PanelFebruary 20-21, May 29-30, August 27-28, November 20-2112521
Radiological Devices PanelFebruary 4, May 20, August 12, November 1812526
National Mammography Quality Assurance Advisory CommitteeApril 7-8, September 8-912397
Technical Electronic Product Radiation Safety Standards CommitteeJune 1812399
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeMay 15, September 1512548
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and ContaminantsFebruary 10-13, June 23-2512560
Science Advisory Board to the National Center for Toxicological ResearchJune 3-512559
Start Signature

Dated: December 12, 2002.

William K. Hubbard,

Associate Commissioner for Policy and Planning.

End Signature End Supplemental Information

[FR Doc. 02-31994 Filed 12-18-02; 8:45 am]

BILLING CODE 4160-01-S